| Title |
Author |
Type |
Date |
Words |
| Amneal Launches Generic Abiraterone Acetate Tablets, USP, 500 mg, Following ANDA Approval by FDA. |
|
|
Jan 8, 2021 |
250 |
| Lantheus Holdings successfully submits PyL NDA with the FDA for the treatment of prostate cancer. |
|
|
Dec 10, 2020 |
262 |
| Lantheus Holdings successfully submits PyL NDA with the FDA for the treatment of prostate cancer. |
|
|
Dec 10, 2020 |
258 |
| Efficacy of Chemotherapy Combinations in Metastatic Castration-Resistant Prostate Cancer Patients - Do Homologous Recombination Deficiency Affect the Outcomes? |
Yekeduz, Emre; Utkan, Gungor; Urun, Yuksel |
|
Dec 1, 2020 |
998 |
| Real-world evidence in patient-reported outcomes (PROs) of metastatic castrate-resistant prostate cancer (mCRPC) patients treated with abiraterone acetate + prednisone (AA+P) across Canada: Final results of COSMiC. |
Gotto, Geoffrey; Drachenberg, Darrel E.; Chin, Joseph; Casey, Richard; Fradet, Vincent; Sabbagh, Rob |
Report |
Dec 1, 2020 |
3969 |
| Rab21, an Endocytic Rab GTPase, is Involved in Drug Resistance in Prostate Cancer Cells. |
|
Report |
Nov 24, 2020 |
4121 |
| Astellas Says Xtandi Approved In China As Prostate Cancer Drug. |
|
|
Nov 6, 2020 |
161 |
| Caretakers, survivors narrate trials during cancer treatment. |
|
|
Oct 14, 2020 |
1472 |
| AstraZeneca receives double EU recommendation for cancer drug. |
|
|
Sep 22, 2020 |
341 |
| My prostate lifeline; Grandad alive thanks to cancer drug a decade after being given 2 years to live. |
EXCLUSIVE BY martin bagot Health & Science Editor |
|
Aug 31, 2020 |
640 |
| FDA Approves FoundationOne Liquid CDx to Serve as Rubraca Companion Diagnostic to Identify Eligible Patients with BRCA1/2-Mutant, Metastatic Castration-Resistant Prostate Cancer. |
|
|
Aug 27, 2020 |
700 |
| Gene discovery may open new treatment for prostate cancer; A gene that fuels the spread of prostate cancer has been discovered by scientists. |
Mark Waghorn |
|
Jul 20, 2020 |
315 |
| lncRNA PCGEM1 strengthens anti-inflammatory and lung protective effects of montelukast sodium in children with cough-variant asthma. |
Xu, Zhenxing; Meng, Lingling; Xie, Yuejuan; Guo, Wei |
|
Jul 1, 2020 |
5896 |
| Drug could help with prostate cancer. |
|
|
Jun 22, 2020 |
202 |
| New cancer drug created; Health: Aberdeen University scientists in pioneering work to tackle disease. |
NEIL DRYSDALE |
|
Jun 20, 2020 |
423 |
| US FDA grants orphan drug designation to Leap Therapeutics' DKN-01. |
|
|
Jun 12, 2020 |
154 |
| Prostate cancer: Breast cancer drug olaparib has the potential to be the world's first precision medicine for prostate cancer, writes Amy Packer. |
Amy Packer |
|
May 26, 2020 |
1142 |
| PROSTATE CANCER: the new hope; Breast cancer drug olaparib has the potential to be the world's first precision medicine for prostate cancer, writes. |
AMY PACKER |
|
May 26, 2020 |
1156 |
| PAWPAW SEEDS AID TREATMENT OF CANCER, ULCER, INFECTIONS, OTHERS -STUDIES. |
|
|
May 21, 2020 |
406 |
| Myriad Genetics receives FDA approval of BRACAnalysis CDx as Lynparza companion. |
|
|
May 20, 2020 |
159 |
| Rubraca Approved in the US as Monotherapy Treatment for Patients with BRCA1/2-Mutant, Metastatic Castration-Resistant Prostate Cancer (mCRPC) Who Have Been Treated with Androgen Receptor-Directed Therapy and a Taxane-Based Chemotherapy. |
|
|
May 18, 2020 |
340 |
| Clovis says FDA approves Rubraca tablets for BRCA mutation-associated mCRPC. |
|
|
May 15, 2020 |
212 |
| Drug could target cancer weakness; New treatment set to be approved following positive trials. |
DAVID BANNER newsdesk@mnamedia.co.uk |
|
Apr 29, 2020 |
469 |
| Drug could target cancer weakness; New treatment set to be approved following positive trials. |
DAVID BANNER newsdesk@mnamedia.co.uk |
|
Apr 29, 2020 |
469 |
| AstraZeneca cancer drug passes prostate trial milestone. |
|
|
Apr 25, 2020 |
221 |
| Keeping active is the best prostate cancer medicine. |
DR MIRIAM STOPPARD |
|
Apr 21, 2020 |
452 |
| Long-Term Infliximab Treatment in Psoriasis Patients: A National Multicentre Retrospective Study. |
Carlet, Clementine; Bichard, Damien; Richard, Marie Aleth; Mahe, Emmanuel; Saillard, Ciemence; Brena |
|
Mar 31, 2020 |
2051 |
| Mathematical Prostate Cancer Evolution: Effect of Immunotherapy Based on Controlled Vaccination Strategy. |
Badziul, Dorota; Jakubczyk, Pawel; Chotorlishvili, Levan; Toklikishvilie, Zaza; Traciak, Julian; Jak |
|
Jan 1, 2020 |
4507 |
| Isolated Testicular Metastasis Diagnosed More than a Decade and a Half Post Primary Treatment for Prostate Cancer. |
Abou Heidar, Nassib F.; Bustros, Gerges; Asmar, Jose M. El-; Zein Sabatto, Bassel; Degheili, Jad A. |
|
Dec 31, 2019 |
2758 |
| Xtandi Approved by US FDA for the Treatment of Metastatic Castration-Sensitive Prostate Cancer. |
|
|
Dec 19, 2019 |
224 |
| Pfizer Inc and Astellas Pharma Inc partnership wins FDA approval for sNDA for XTANDI to treat metastatic castrationsensitive prostate cancer. |
|
|
Dec 17, 2019 |
256 |
| Pfizer Inc and Astellas Pharma Inc partnership wins FDA approval for sNDA for XTANDI to treat metastatic castrationsensitive prostate cancer. |
|
|
Dec 17, 2019 |
252 |
| Global Prostate Cancer Drugs Market Report 2020. |
|
Report |
Dec 11, 2019 |
840 |
| Advaxis Submits IND Application to US FDA for ADXS-HOT Drug Candidate for Prostate Cancer. |
|
|
Dec 6, 2019 |
363 |
| Men with prostate cancer can live longer on immunotherapy, study finds. |
ANI |
|
Nov 30, 2019 |
558 |
| Another big step forward for treatment of prostate cancer. |
DR MIRIAM STOPPARD |
Disease/Disorder overview |
Nov 29, 2019 |
428 |
| Prostate cancer can rely on immunotherapy for treatment: Study. |
ANI |
|
Nov 28, 2019 |
539 |
| China's regulator approves Astellas Pharma's new drug application for XTANDI. |
|
|
Nov 26, 2019 |
198 |
| China's regulator approves Astellas Pharma's new drug application for XTANDI. |
|
|
Nov 26, 2019 |
194 |
| Gene-Based Therapy Helps Fight Advanced Prostate Cancer. |
Amy Norton, HealthDay Reporter |
|
Sep 30, 2019 |
801 |
| Inflammatory Biomarkers as Predictors of Response to Immunotherapy in Urological Tumors. |
Schepisi, Giuseppe; Brighi, Nicole; Cursano, Maria Concetta; Gurioli, Giorgia; Ravaglia, Giorgia; Al |
|
Sep 30, 2019 |
8889 |
| SBRT Shortens Tx for Prostate Cancer Without Greater Toxicity; Ultra-hypofractionated stereotactic body radiotherapy cuts treatment from two months to two weeks. |
|
|
Sep 27, 2019 |
290 |
| Prostate Cancer Cure: New Drug Family Could Combat Disease Better. |
Johnny Vatican |
|
Sep 23, 2019 |
468 |
| Sir Rod free of cancer after secret treatment. |
|
|
Sep 16, 2019 |
138 |
| BioXcel Therapeutics receives Orphan Drug Designation for BXCL701. |
|
|
Sep 4, 2019 |
187 |
| AHA News: Common Prostate Cancer Treatment May Increase Risk of Fatal Heart Condition. |
|
|
Aug 5, 2019 |
561 |
| Nubeqa Available at Biologics by McKesson. |
|
|
Aug 5, 2019 |
425 |
| Astellas Pharma Inc. - Astellas Submits Supplemental New Drug Application for Approval of Additional Indication of XTANDI[R] for the Treatment of Men with Metastatic Hormone-Sensitive Prostate Cancer in Japan -- 30/7/2019. |
|
|
Aug 2, 2019 |
331 |
| Chemo drugs too toxic for Africans - experts. |
|
|
Aug 1, 2019 |
807 |
| Bayer wins FDA approval for Nubeqa to treat men with non-metastatic castration-resistant prostate cancer. |
|
|
Jul 31, 2019 |
278 |
| Bayer wins FDA approval for Nubeqa to treat men with non-metastatic castration-resistant prostate cancer. |
|
|
Jul 31, 2019 |
274 |
| New Data Ease Concerns About Prostate Drugs: Long-term findings affirm safety of BPH medications, while suggesting a cancer-prevention benefit. |
|
|
Jul 25, 2019 |
1230 |
| Incontinent sex offender died after moaning he was 'aching all over like a toothache'; The 89-year-old needed a zimmer frame to get around the jail as he shunned cancer treatment. |
|
|
Jul 20, 2019 |
413 |
| MSN Labs/Novadoz Pharmaceuticals announces US FDA approval of Abiraterone. |
|
|
Jul 16, 2019 |
156 |
| MSN Labs/Novadoz Pharmaceuticals announces US FDA approval of Abiraterone. |
|
|
Jul 16, 2019 |
160 |
| Dementia linked to hormone blocking prostate cancer treatment. |
|
|
Jul 11, 2019 |
408 |
| Hormone Treatment for Prostate Cancer Linked to Heightened Alzheimer's Risk. |
|
|
Jul 8, 2019 |
740 |
| Dementia link found in prostate cancer treatment. |
|
|
Jul 6, 2019 |
199 |
| Breakthrough in treatment of prostate cancer. |
|
|
Jun 30, 2019 |
348 |
| Test to help treatment of male cancer. |
|
|
Jun 26, 2019 |
178 |
| Genitourinary Cancers Treatment Market Expectations & Growth Trends Highlighted until 2026. |
|
|
Jun 20, 2019 |
836 |
| Veru adds VERU-100 to prostate cancer drug development pipeline. |
|
|
Jun 4, 2019 |
177 |
| New drugs make headway against several cancers. |
|
|
Jun 3, 2019 |
702 |
| Men choose active surveillance for early age prostate cancer instead of treatment. |
|
|
Jun 1, 2019 |
520 |
| Re: Cannabinoids as an Anticancer Agent for Prostate Cancer. |
Roberto, Domenica; Klotz, Laurence H.; Venkateswaran, Vasundara |
|
Jun 1, 2019 |
294 |
| Immunotherapy in Prostate Cancer. |
Bolat, Deniz; Haydaroglu, Ayfer |
|
Jun 1, 2019 |
4730 |
| Elekta announces treatment of first cancer patient at The Christie NHS Foundation Trust with Elekta Unity. |
|
|
May 22, 2019 |
195 |
| Elekta announces treatment of first cancer patient at The Christie NHS Foundation Trust with Elekta Unity. |
|
|
May 22, 2019 |
197 |
| Bayer, Orion say FDA grants priority review for darolutamide. |
|
|
Apr 29, 2019 |
165 |
| Hormonal treatment may trigger depression in men with prostate cancer: Study. |
|
|
Mar 18, 2019 |
447 |
| Cancer treatment. |
|
|
Feb 10, 2019 |
297 |
| New treatment could benefit cancer patients. |
|
|
Feb 2, 2019 |
329 |
| Eli Lilly wins US FDA's approval for new indication of ALIMTA (pemetrexed for injection) and KEYTRUDA (pembrolizumab) combination for NSCLC. |
|
|
Feb 1, 2019 |
321 |
| Eli Lilly wins US FDA's approval for new indication of ALIMTA (pemetrexed for injection) and KEYTRUDA (pembrolizumab) combination for NSCLC. |
|
|
Feb 1, 2019 |
317 |
| New approach to prostate cancer therapy is making treatment easier for patients in Newcastle; The Northern Centre for Cancer Care is the first hospital in the UK to use new technology which makes radiotherapy for prostate cancer more effective. |
|
|
Jan 31, 2019 |
440 |
| Miller getting 'best treatment' for prostate cancer. |
|
|
Jan 30, 2019 |
139 |
| Iran Produces New Drug for Cancer Patients. |
|
|
Dec 17, 2018 |
507 |
| Cancer Targeted Technology Files Investigational New Drug Application for CTT1403, a Novel Radiotherapeutic Drug for Prostate Cancer. |
|
|
Nov 12, 2018 |
286 |
| New tech sets perfect drug dose for cancer. |
|
|
Nov 6, 2018 |
408 |
| New tech sets perfect drug dose for cancer; miriam@mirror.co.uk @MiriamStoppard. |
|
|
Nov 6, 2018 |
406 |
| Myovant Sciences: Enrollment complete in Phase 3 HERO trial of relugolix. |
|
|
Oct 24, 2018 |
128 |
| Progenics advances prostrate cancer treatment to phase 2 after FDA discussions. |
|
|
Oct 11, 2018 |
226 |
| Patient tests 'cancer cure in single treatment'. |
|
|
Sep 25, 2018 |
132 |
| Endocyte announces FDA acceptance of rPFS alternative endpoint in VISION trial. |
|
|
Sep 10, 2018 |
234 |
| Pfizer and Astellas announce amendments to phase 3 trials of prostate cancer drug XTANDI. |
|
|
Aug 24, 2018 |
372 |
| Pfizer and Astellas announce amendments to phase 3 trials of prostate cancer drug XTANDI. |
|
|
Aug 24, 2018 |
368 |
| Kanye West bonding with dad during cancer treatment. |
|
|
Aug 2, 2018 |
122 |
| Prognostic and predictive clinical factors in patients with metastatic castration-resistant prostate cancer treated with cabazitaxel. |
Yokom, Daniel W.; Stewart, John; Alimohamed, Nimira S.; Winquist, Eric; Berry, Scott; Hubay, Stacey; |
Report |
Aug 1, 2018 |
6007 |
| Blood tests can predict treatment for advanced prostate cancer. |
|
|
Jul 25, 2018 |
366 |
| Leap Therapeutics announces collaboration with Merck KGaA, Pfizer. |
|
|
Jul 23, 2018 |
142 |
| Pfizer reports FDA approves sNDA to broaden XTANDI indication. |
|
|
Jul 13, 2018 |
110 |
| Enzalutamide Improves Outcomes for Aggressive Prostate Cancer; Treatment led to 71 percent lower risk of metastasis or death compared to placebo. |
|
|
Jun 28, 2018 |
284 |
| Prostate Cancer Treatment Side Effects Linked to Distress; Those with worse emotional distress also report worse urinary, sexual, bowel functions. |
|
|
Jun 8, 2018 |
196 |
| Dendreon Releases New Data in Clinical Cancer Research Connecting Provenge Treatment with Targeted Killer T Cell Generation in Prostate Cancer. |
|
|
Jun 6, 2018 |
227 |
| New Treatment Option for Prostate Cancer. |
|
|
Jun 1, 2018 |
278 |
| Oak Ridge Lab Ramps Up Production of Key Radioisotope for Cancer-Fighting Drug. |
|
|
May 31, 2018 |
431 |
| US FDA Grants Approval to Sun Pharma Subsididary for Yonsa (abiraterone acetate) for Treatment of MCRPC in Combination with Methylprednisolone. |
|
|
May 25, 2018 |
351 |
| From 2008 to 2014, Prostate Cancer Testing, Treatment Down; Sharpest decrease seen in privately insured men after 2011. |
|
|
May 22, 2018 |
225 |
| Short-course radiotherapy treatment safe for prostate cancer patients. |
|
|
Apr 23, 2018 |
682 |
| Managing the Side Effects of Prostate Cancer Treatment. |
|
|
Apr 21, 2018 |
1048 |
| Pfizer and Astellas Pharma submit supplemental New Drug Application to US FDA for Xtandi. |
|
|
Mar 21, 2018 |
229 |
| Pfizer and Astellas Pharma submit supplemental New Drug Application to US FDA for Xtandi. |
|
|
Mar 21, 2018 |
225 |
| Pfizer, Astellas Seek to Expand Indication of Xtandi to include Men with Non-metastatic CRPC. |
|
|
Mar 21, 2018 |
304 |
| Pfizer, Astellas say sNDA for XTANDI granted priority review by FDA. |
|
|
Mar 19, 2018 |
179 |
| The US Food and Drug Administration approves Janssen Pharmaceutical's Erleada. |
|
|
Feb 16, 2018 |
176 |
| The US Food and Drug Administration approves Janssen Pharmaceutical's Erleada. |
|
|
Feb 16, 2018 |
172 |
| FDA Approves Erleada to Treat Non-Metastatic Prostate Cancer; First FDA-approved treatment for non-metastatic, castration-resistant prostate cancer. |
|
|
Feb 14, 2018 |
197 |
| Prostate Cancer: Symptoms and Treatment. |
|
|
Feb 5, 2018 |
469 |
| Fat drug 'can help prostate cancer fight'. |
|
|
Jan 16, 2018 |
125 |
| Case: Testicular oligometastasis from prostate cancer--Report of rare isolated recurrence after radiotherapy and intermittent androgen-deprivation therapy. |
Cho, Chan-Kyung J.; Sigurdson, Samantha; Davidson, Christopher M.; Leveridge, Michael; Mahmud, Aamer |
Clinical report |
Jan 1, 2018 |
1729 |
| Janssen Biotech passes the US FDA's priority review designation for the New Drug Application (NDA) for apalutamide for prostate cancer. |
|
|
Dec 22, 2017 |
282 |
| Janssen Biotech passes the US FDA's priority review designation for the New Drug Application (NDA) for apalutamide for prostate cancer. |
|
|
Dec 22, 2017 |
278 |
| 2 MINUTES ON; Genetic tests to target prostate cancer treatment. |
|
|
Nov 27, 2017 |
283 |
| 2MINUTES ON; Genetic tests to target prostate cancer treatment. |
|
|
Nov 27, 2017 |
283 |
| Anti-clot drug fights cancer. |
|
|
Nov 7, 2017 |
105 |
| Common asthma drug 'stops spread of prostate cancer' 2 MINUTES ON. |
|
|
Oct 23, 2017 |
222 |
| 2 MINUTES ON; Common asthma drug 'stops spread of prostate cancer'. |
|
|
Oct 23, 2017 |
222 |
| 2 MINUTES ON; DR MIRIAM STOPPARD; Helping to keep you fit and healthy; Common asthma drug 'stops spread of prostate cancer'. |
|
|
Oct 23, 2017 |
222 |
| Trovagene PLK1 Inhibitor Enhances Activity of Zytiga in Castration-resistant Prostate Cancer Tumor Cells. |
|
|
Oct 19, 2017 |
265 |
| NanOlogy Enrolls First Patient in Clinical Trial of NanoPac for Treatment of Prostate Cancer. |
|
|
Oct 17, 2017 |
365 |
| Pioneering treatment for cancer is a success. |
|
|
Sep 26, 2017 |
368 |
| Treatment boost for prostate cancer. |
|
|
Sep 26, 2017 |
389 |
| Observation an effective prostate cancer treatment. |
|
|
Sep 22, 2017 |
144 |
| RECIPHARM & LIDDS MANUFACTURE CANCER DRUG IN SWEDEN. |
|
|
Sep 1, 2017 |
497 |
| Kastrasyon Direncli Prostat Kanserinde Dosetaksel Kemoterapisinin Etkinligi: Tek Merkez Deneyimi/The Eficiency of Docetaxel Chemotherapy on Castration Resistant Prostate Cancer: Singe Center Experience. |
Suer, Evren; Hamidi, Nurullah; Gokce, Mehmet Ilker; Baltaci, Sumer |
Report |
Sep 1, 2017 |
2711 |
| CDISC Releases Therapeutic Area User Guide to Assist in Discovery of New Treatments for Prostate Cancer. |
|
|
Aug 15, 2017 |
316 |
| Madison Vaccines Doses First Patient in Trial of MVI-816 Plus Keytruda for Metastatic, Treatment-Resistant Prostate Cancer. |
|
|
Aug 4, 2017 |
308 |
| New treatment for advanced prostate cancer. |
|
|
Aug 1, 2017 |
188 |
| New drugs combination could save 20,000 men; Breakthrough study into prostate cancer treatment. |
|
|
Jun 8, 2017 |
534 |
| Johnson & Johnson's prostate cancer drug Zytiga shows promise in trial. |
|
|
Jun 6, 2017 |
143 |
| Johnson & Johnson's prostate cancer drug Zytiga shows promise in trial. |
|
|
Jun 6, 2017 |
139 |
| Boost for prostate cancer treatment; SUNDAY SHORTS. |
|
|
Jun 4, 2017 |
200 |
| Prostate Cancer Treatment Market is Expected to Reach US$ 18.4 Bn by 2025. |
|
|
Apr 21, 2017 |
386 |
| ValiRx to extend early stage trial of VAL201 prostate cancer drug. |
|
|
Jan 12, 2017 |
200 |
| ValiRx to extend early stage trial of VAL201 prostate cancer drug. |
|
|
Jan 12, 2017 |
196 |
| Valeant announces USD819.9m divestiture of Dendreon. |
|
|
Jan 10, 2017 |
182 |
| Valeant announces USD819.9m divestiture of Dendreon. |
|
|
Jan 10, 2017 |
178 |
| Organic Compounds Based on (E)-N-Aryl-2-ethene-sulfonamide as Microtubule Targeted Agents in Prostate Cancer: QSAR Study. |
Hadaji, El Ghalia; Bourass, Mohamed; Ouammou, Abdelkarim; Bouachrine, Mohammed |
Report |
Jan 1, 2017 |
8970 |
| Salinomycin Exerts Anticancer Effects on PC-3 Cells and PC-3-Derived Cancer Stem Cells In Vitro and In Vivo. |
Zhang, Yunsheng; Liu, Luogen; Li, Fang; Wu, Tao; Jiang, Hongtao; Jiang, Xianxun; Du, Xiaobo; Wang, Y |
Report |
Jan 1, 2017 |
5385 |
| Prostate Cancer Radiation Therapy: What Do Clinicians Have to Know? |
Vanneste, Ben G.L.; Van Limbergen, Evert J.; van Lin, Emile N.; van Roermund, Joep G.H.; Lambin, Phi |
Report |
Jan 1, 2017 |
10714 |
| Neutrophil-to-Lymphocyte Ratio Predicts Prognosis in Castration-Resistant Prostate Cancer Patients Who Received Cabazitaxel Chemotherapy. |
Uemura, Koichi; Kawahara, Takashi; Yamashita, Daisuke; Jikuya, Ryosuke; Abe, Koichi; Tatenuma, Tomoy |
Report |
Jan 1, 2017 |
3550 |
| Potential Anticancer Mechanisms of a Novel EGFR/DNA-Targeting Combi-Molecule (JDF12) against DU145 Prostate Cancer Cells: An iTRAQ-Based Proteomic Analysis. |
Zheng, Haofeng; Liang, Guancan; Chen, Yanxiong; Lin, Sijie; Liu, Wei; Fang, Youqiang |
Report |
Jan 1, 2017 |
6028 |
| I got hot flushes from prostate cancer drugs; ME & MY BODY: MARTIN 'WOLFIE' ADAMS. |
|
|
Nov 1, 2016 |
1065 |
| New drug disrupts growth signaling. |
|
|
Oct 1, 2016 |
365 |
| MicroRNA Theranostics in Prostate Cancer Precision Medicine. |
Matin, Farhana; Jeet, Varinder; Clements, Judith A.; Yousef, George M.; Batra, Jyotsna |
|
Oct 1, 2016 |
12287 |
| Radioactive drug set to treat cancer patients. |
|
|
Sep 2, 2016 |
257 |
| Decision needed on crucial cancer drug; Views of Wales. |
|
|
Jul 21, 2016 |
218 |
| TOLMAR Pharmaceuticals receives FDA label update approval for ELIGARD prostate cancer drug. |
|
|
May 10, 2016 |
142 |
| TOLMAR Pharmaceuticals receives FDA label update approval for ELIGARD prostate cancer drug. |
|
|
May 10, 2016 |
138 |
| Retrospective audit: does prior assessment by oral and maxillofacial surgeons reduce the risk of osteonecrosis of the jaw in patients receiving bone-targeted therapies for metastatic cancers to the skeleton?--Part II. |
Turner, Bruce; Ali, Sacha; Pati, Jhumur; Nargund, Vinod; Ali, Enamul; Cheng, Leo; Wells, Paula |
Report |
May 1, 2016 |
4029 |
| Aspirin lowers risk of advanced prostate cancer. |
|
Brief article |
Apr 1, 2016 |
255 |
| Assessing the utility of cabazitaxel in mCRPC. |
North, Scott A. |
Report |
Mar 1, 2016 |
1406 |
| Routine drug can help in prostate cancer care. |
|
|
Dec 21, 2015 |
409 |
| Common prostate cancer treatment may double Alzheimer's risk. |
|
|
Dec 9, 2015 |
375 |
| Cancer Targeted Technology Receives USD 2.3m Fast-Track Contract to Develop Prostate Cancer Treatment. |
|
|
Dec 7, 2015 |
332 |
| 9 MILES; SCANDAL OF NHS POSTCODE LOTTERY; The difference between me dying any day or getting a cancer drug and spending Christmas with my grandkids is a cruel; EXCLUSIVE. |
|
|
Oct 25, 2015 |
1201 |
| 9 MILES; SCANDAL OF NHS POSTCODE LOTTERY; The difference between me dying any day or getting a cancer drug and spending Christmas with my grandkids is a cruel... |
|
|
Oct 25, 2015 |
1208 |
| Docetaxel extends survival in metastatic prostate ca. |
Nelson, Roxanne |
|
Sep 15, 2015 |
690 |
| Cancer drug made available. |
|
|
Sep 9, 2015 |
185 |
| New drug for prostate cancer. |
|
|
Sep 9, 2015 |
174 |
| Prostate cancer: summary from ASCO 2015. |
|
Case note |
Aug 1, 2015 |
2295 |
| Metformin shows promise for late-stage prostate cancer. |
|
Brief article |
Jun 1, 2015 |
164 |
| Cystatin C for therapeutic drug monitoring. |
Rebollo, Noemi; Cepeda-Piorno, Francisco Javier |
Clinical report |
Jun 1, 2015 |
2507 |
| Drug offers more time to prostate cancer patients. |
|
|
May 18, 2015 |
506 |
| Smokers fare worse after prostate cancer radiation treatment. |
|
|
Apr 1, 2015 |
155 |
| Iran Breaks US Monopoly on Mass-Production of Prostate Cancer Medicine. |
|
|
Feb 3, 2015 |
171 |
| POTENTIAL PROSTATE CANCER TREATMENT COMBO. |
|
|
Dec 1, 2014 |
104 |
| Men uneducated about their prostate cancer have trouble making treatment choices. |
|
|
Dec 1, 2014 |
257 |
| Complete response to ethnylestradiol prolonged for almost two years in patients with castration-resistant prostate cancer. |
Hongo, Hiroshi; Kosaka, Takeo; Oya, Mototsugu |
Case study |
Dec 1, 2014 |
1270 |
| Diplomat pharmacies announces expanded FDA approval for XTANDI (enzalutamide) prostate cancer drug. |
|
|
Oct 2, 2014 |
178 |
| Diplomat pharmacies announces expanded FDA approval for XTANDI (enzalutamide) prostate cancer drug. |
|
|
Oct 2, 2014 |
174 |
| GenomeDx's Decipher prostate cancer test influences treatment decisions, improves patient outcomes. |
|
Clinical report |
Sep 16, 2014 |
352 |
| Metformin aids in the stabilization of metastatic prostate cancer. |
Dye, D. |
Brief article |
Sep 1, 2014 |
161 |
| A multicentre analysis of abiraterone acetate in Canadian patients with metastatic castration-resistant prostate cancer. |
Clayton, Ravinder; Wu, Jackson; Heng, Daniel Y.; North, Scott A.; Emmenegger, Urban; Hotte, Sebastie |
Report |
Sep 1, 2014 |
3493 |
| GenomeDx Biosciences' Decipher prostate cancer classifier shows best treatment options post-surgery. |
|
|
Jul 31, 2014 |
269 |
| Novel approaches in the high-risk prostate cancer patient: Summary of key research presented at AUA 2014. |
|
Report |
Jul 1, 2014 |
673 |
| Could an 'Old School Drug' Prolong Prostate Cancer Patients' Lives? |
|
|
Jun 2, 2014 |
356 |
| Robotic surgery may be better treatment for prostate cancer. |
|
|
May 1, 2014 |
423 |
| GLOBAL PARTNERS DEVELOP PROSTATE CANCER DRUG. |
|
|
Apr 1, 2014 |
788 |
| Phase 2 clinical trial demonstrates benefits of metformin. |
Pryce, A. |
Brief article |
Apr 1, 2014 |
183 |
| Dismay over rejection of prostate cancer drug. |
|
|
Mar 25, 2014 |
368 |
| Canadian content at GU-ASCO 2014: Highlights of research involving Canadian researchers. |
Kapoor, Anil |
Conference notes |
Mar 1, 2014 |
2105 |
| What's new in prostate cancer research? Highlights of GU-ASCO 2014. |
Kapoor, Anil |
Report |
Mar 1, 2014 |
3451 |
| Early diagnosis key to prostate cancer treatment. |
|
Disease/Disorder overview |
Feb 18, 2014 |
424 |
| Fighting for cancer drug; Views of the North. |
|
|
Feb 5, 2014 |
311 |
| Charity's plea over prostate cancer drug. |
|
|
Feb 3, 2014 |
109 |
| 'New drug to cut prostate cancer toll'. |
|
|
Jan 17, 2014 |
115 |
| The Avodart[R] - Proscar[R] Debate. |
Faloon, William |
|
Dec 1, 2013 |
6130 |
| A phase I dose-escalation study of oral BR-DIM (bioresponse 3,3'- diindolylmethane) in castrate-resistant, non-metastatic prostate cancer. |
|
|
Dec 1, 2013 |
347 |
| Headlines your Health: study confirms drug's benefits for prostate cancer prevention. |
|
|
Dec 1, 2013 |
328 |
| Attenuation of nucleoside and anti-cancer nucleoside analog drug uptake in prostate cancer cells by cimicifuga racemosa extract BNO-1055. |
Dueregger (a), (b), Andrea; Guggenberger (a), Fabian; Barthelmes (c), Jan; Stecher (d), Gunther; Sch |
Report |
Nov 15, 2013 |
4969 |
| GAUN YERSEL BIG YIN; Pals rally round as star Billy battles Parkinson's and prostate cancer Pals rally round Big Yin after shock of diagnosis. |
|
|
Sep 17, 2013 |
562 |
| Comparison of tolerability and adverse events following treatment with two GnRH agonists in patients with advanced prostate cancer. |
Shore, Neal D.; Sieber, Paul; Schimke, Leanne; Perzin, Adam; Olsen, Scott |
Report |
Sep 1, 2013 |
4743 |
| Drug safely cuts prostate cancer risk. |
Marchione, Marilyn |
|
Aug 15, 2013 |
383 |
| Nuclear medicine in oncology 2: breast, prostate, and cervical cancer, melanoma, and neuro-endocrine tumours: nuclear medicine approaches to cancer detection, staging and treatment. |
Kotze, T. |
|
Aug 1, 2013 |
2549 |
| Too few men receiving prostate cancer treatment are getting bone density scans. |
|
|
Jul 1, 2013 |
183 |
| US FDA APPROVES XOFIGO (RADIUM-223 DICHLORIDE). |
|
|
Jun 1, 2013 |
1008 |
| Chicken-killing virus identified as promising treatment for human prostate cancer. |
|
|
Apr 9, 2013 |
424 |
| Long-term side effects similar between prostate cancer treatments. |
|
|
Apr 1, 2013 |
232 |
| Many factors are carefully be considered; Neil Fenn, a consultant urological surgeon at ABMU Health Board, looks at the role surgery plays in treatment of prostate cancer. |
|
|
Mar 4, 2013 |
516 |
| Skin patches may be safer treatment for prostate cancer than hormone injections. |
|
|
Mar 4, 2013 |
273 |
| Long-term outcomes of treatment for prostate cancer. |
|
|
Mar 1, 2013 |
286 |
| Newcastle disease virus shows promise as safe prostate cancer treatment. |
|
|
Feb 26, 2013 |
364 |
| Prostate cancer cells that defy treatment. |
|
|
Feb 1, 2013 |
111 |
| What matters: discussing prostate cancer treatment options. |
Ebbert, Jon O. |
|
Feb 1, 2013 |
411 |
| Post-docetaxel options for further survival benefit in metastatic castration-resistant prostate cancer: Questions of choice. |
Asselah, Jamil; Sperlich, Catherine |
Report |
Feb 1, 2013 |
3029 |
| Optimal management of patients receiving cabazitaxel-based chemotherapy. |
Sperlich, Catherine; Saad, Fred |
Report |
Feb 1, 2013 |
5351 |
| Chemotherapy for prostate cancer: Clinical practice in Canada. |
Saad, Fred; Asselah, Jamil |
Report |
Feb 1, 2013 |
3448 |
| Emerging molecularly targeted therapies in castration refractory prostate cancer. |
Patel, Jesal C.; Maughan, Benjamin L.; Agarwal, Archana M.; Batten, Julia A.; Zhang, Tian Y.; Agarwa |
|
Jan 1, 2013 |
7598 |
| Debiopharm Group unveils Pamorelin LA in India for the treatment of prostate cancer. |
|
|
Dec 10, 2012 |
194 |
| Debiopharm Group unveils Pamorelin LA in India for the treatment of prostate cancer. |
|
|
Dec 10, 2012 |
190 |
| The use of nutritional and herbal supplements in the maintenance of prostate health: an independent review of complementary medicine evidence. |
Setright, Russell |
Reprint |
Dec 1, 2012 |
6849 |
| PROSTATE CANCER WONDER PILL HERE; Drug will extend lives of men hit by killer disease. |
|
|
Nov 15, 2012 |
333 |
| Medivation Inc & Astellas Pharma Inc receives US FDA's approval for XTANDI for patients with metastatic castration-resistant prostate cancer. |
|
|
Sep 3, 2012 |
168 |
| Medivation Inc & Astellas Pharma Inc receives US FDA's approval for XTANDI for patients with metastatic castration-resistant prostate cancer. |
|
|
Sep 3, 2012 |
164 |
| Observation of infiltration and activation of dendritic cells in primary foci of prostate cancer using fuzhengyiliufa integrative treatments. |
Pan, Ming-wo; Ye, Ning; Chen, Zhi-qiang; Gu, Chi-ming; Lim, Chi Eung Danforn |
Report |
Sep 1, 2012 |
1687 |
| New drug extends life in men with advanced prostate cancer. |
|
|
Aug 16, 2012 |
552 |
| John Hopkins develops anticancer drug. |
|
|
Jul 10, 2012 |
723 |
| John Hopkins says develops anticancer drug. |
|
|
Jul 10, 2012 |
723 |
| MP hails prostate cancer treatment. |
|
|
Jul 2, 2012 |
165 |
| Intermittent therapy inferior to hormone therapy for prostrate cancer. |
|
|
Jun 4, 2012 |
801 |
| New Drug Slows Advanced Prostate Cancer. |
|
Clinical report |
Jun 4, 2012 |
781 |
| Prostate cancer drug gets approval. |
|
|
May 16, 2012 |
279 |
| Stimulation of a non-functioning pituitary macroadenoma after administration of goserelin acetate for locally advanced prostate cancer causing a sustained elevation in PSA and testosterone. |
Youssef, Fady R.; Robinson, Robert T.; Boucher, Nigel R. |
Clinical report |
Apr 1, 2012 |
1717 |
| Sipuleucel-T (Provenge[R]): immunotherapy for metastatic prostate cancer. |
Gaines, Kaye K. |
Report |
Mar 1, 2012 |
2922 |
| Give us your views on cancer treatment; views. |
|
|
Dec 23, 2011 |
262 |
| Panel endorses active monitoring and delay of treatment for low-risk prostate cancer. |
|
Brief article |
Dec 8, 2011 |
101 |
| Mugabe 'secretly receiving prostate cancer treatment in Singapore'. |
|
|
Oct 3, 2011 |
186 |
| Prostate cancer drug 'too costly for NHS' Chemo medicine can prolong life. |
|
|
Sep 30, 2011 |
337 |
| Bone-strengthening drug 'could ease pain in prostate cancer patients'. |
|
|
Sep 26, 2011 |
199 |
| TREATMENT BOOST FOR PROSTATE CANCER SUFFERERS; Hope in disease battle. |
|
|
Sep 19, 2011 |
297 |
| Headlines & your health: FDA approves drug for late-stage prostate cancer. |
|
|
Jul 1, 2011 |
292 |
| New drug shows promise in stopping prostate cancer spread to bone. |
|
|
Jun 8, 2011 |
270 |
| Randomized study evaluating testosterone recovery using short-versus long-acting luteinizing hormone releasing hormone agonists. |
Pai, Howard Huaihan; Pickles, Tom; Keyes, Mira; Jones, Stuart; McDonald, Rachel E.; Lesperance, Mary |
Clinical report |
Jun 1, 2011 |
4901 |
| Half of prostate cancers could be treated with new type of cancer drugs. |
|
|
May 19, 2011 |
222 |
| Heart drug may help fight cancer - research. |
|
|
Apr 3, 2011 |
272 |
| Despite ruling, talk to your doctor about prostate cancer drugs. |
|
|
Apr 1, 2011 |
523 |
| Lloyd-Webber reveals he is impotent after prostate cancer treatment. |
|
|
Mar 31, 2011 |
280 |
| Centocor Ortho Biotech seeks FDA nod for abiraterone acetate for metastatic advanced prostate cancer treatment. |
|
|
Dec 21, 2010 |
212 |
| FDA advisers reject Glaxo, Merck prostate drugs. |
|
|
Dec 6, 2010 |
383 |
| Surgery found effective for aggressive prostate cancer. |
|
|
Dec 1, 2010 |
157 |
| Cancer drug developer Exelixis Inc (South San Francisco CA) said interim data from two mid-stage trials of an experimental drug showed promise in patients with a type of prostate cancer and ovarian cancer, sending its shares up 31% for the week. |
|
|
Nov 22, 2010 |
471 |
| Anticoagulants curb prostate cancer mortality: aspirin leads the pack, lowering the death risk by nearly 50% in a study of more than 5,000 men. |
Sullivan, Michele G. |
Report |
Nov 15, 2010 |
770 |
| FDA delay of one drug causes 82,000 lost life-years. |
Faloon, William |
|
Nov 1, 2010 |
3988 |
| Should you take medications to prevent prostate cancer? If you're at elevated risk of the disease, weigh the pros and cons of finasteride and dutasteride with your doctor. |
|
|
Nov 1, 2010 |
798 |
| Bar raised in metastatic prostate Ca treatment. |
Freeman, Sara |
|
Nov 1, 2010 |
898 |
| Coming soon: 'Magic pill' for men with aggressive prostate cancer. |
|
|
Oct 12, 2010 |
182 |
| Magic pill for men with aggressive prostate cancer. |
|
|
Oct 12, 2010 |
163 |
| When is no treatment best for prostate cancer? Active surveillance may help you delay treatment and its side effects, but weigh the risks and benefits with your physician. |
|
|
Oct 1, 2010 |
1147 |
| Surgery effective for aggressive prostate cancer patients. |
|
|
Sep 28, 2010 |
446 |
| -AstraZeneca abandons registration plans for prostate cancer drug. |
|
|
Sep 27, 2010 |
159 |
| Higher doses of an experimental prostate cancer drug being developed by GTx Inc (Los Angeles CA) were shown in a trial to lower testosterone levels, the male hormone the cancer cells need to grow and spread. |
|
|
Sep 20, 2010 |
501 |
| Researchers urged doctors to discuss with patients the benefits of Merck & Co's (Whitehouse Station NJ) Proscar for preventing prostate cancer, after a study found that prescribing of the product didn't increase even after a 2003 trial showed the medicine wards off tumors. |
|
|
Aug 16, 2010 |
599 |
| Using your immune system to fight prostate cancer: the FDA's approval of a therapeutic vaccine represents a milestone in cancer immunotherapy. |
|
|
Aug 1, 2010 |
603 |
| Wait times in prostate cancer diagnosis and radiation treatment. |
Stevens, Christiaan; Bondy, Susan J.; Loblaw, D. Andrew |
Report |
Aug 1, 2010 |
3805 |
| United States : Sanofi Launches Cancer Treatment. |
|
|
Jul 27, 2010 |
221 |
| Blood vessel-blocking drug may delay prostate cancer progression. |
|
|
Jun 10, 2010 |
252 |
| FDA approves Bayer's OC Natazia: FDA approves Provenge for advanced prostate cancer. |
|
|
Jun 1, 2010 |
1611 |
| Drugs show action against the worst prostate cancer: experimental therapies may improve survival in men with aggressive disease that's resistant to standard treatments. |
Dreicer, Robert |
|
Jun 1, 2010 |
686 |
| Novel technology helps in prostate cancer treatment. |
|
|
May 15, 2010 |
243 |
| Cancer tie to PD drug investigated. |
|
|
May 1, 2010 |
296 |
| Drug offers hope in late-stage prostate cancer. |
|
|
May 1, 2010 |
176 |
| Targeted treatment for prostate cancer to be tested. |
|
|
Apr 17, 2010 |
300 |
| Experimental drug for advanced prostate cancer shows promise. |
|
Clinical report |
Apr 15, 2010 |
221 |
| Reliance on PSA may lead to overtreatment. |
London, Susan |
Report |
Apr 1, 2010 |
472 |
| Prostate drug dutasteride may cut cancer risk. |
|
|
Apr 1, 2010 |
539 |
| A NEW prostate cancer drug [...]. |
|
|
Feb 22, 2010 |
199 |
| Prostate cancer drug hope. |
|
|
Feb 17, 2010 |
179 |
| FDA panel: prostate Ca therapy trials needed. |
Bylander, Jessica |
|
Feb 15, 2010 |
520 |
| Experimental lung cancer drug may help treat brain, prostate cancer. |
|
|
Jan 5, 2010 |
406 |
| Shorter radiation course equivalent to standard treatment for prostate cancer. |
|
|
Jan 1, 2010 |
152 |
| New hope for cancer treatment. |
|
|
Dec 29, 2009 |
164 |
| New Way Paved for Treatment of Hormone-Resistant Prostate Cancer. |
|
|
Dec 19, 2009 |
358 |
| Active Biotech's drug candidate reaches primary endpoint in Phase II trial in prostate cancer patients. |
|
|
Dec 14, 2009 |
182 |
| Combo Tx improves survival in prostate cancer. |
Wendling, Patrice |
|
Dec 1, 2009 |
490 |
| A rapid PSA half-life following docetaxel chemotherapy is associated with improved survival in hormone refractory prostate cancer. |
Hanninen, Mikael; Venner, Peter; North, Scott |
Report |
Oct 1, 2009 |
3211 |
| PSA-based treatment response criteria in castration-resistant prostate cancer: promises and limitations. |
Emmenegger, Urban; Ko, Yoo-Joung |
Clinical report |
Oct 1, 2009 |
1219 |
| Prostate cancer could be delayed by green tea. |
Finkel, Jon |
Brief article |
Oct 1, 2009 |
131 |
| Herbal therapy helps forestall prostate cancer. |
Ninger, Laura J. |
Disease/Disorder overview |
Oct 1, 2009 |
165 |
| Active Biotech says Tasq prostate cancer drug featured in British journal. |
|
|
Sep 25, 2009 |
184 |
| Osteoporosis drug shows promise in tests. |
|
Brief article |
Aug 17, 2009 |
266 |
| Medications may bolster the prostate cancer arsenal: study findings confirm that drugs for enlarged prostate may reduce prostate cancer risk. |
|
|
Aug 1, 2009 |
488 |
| Ultra-sound therapy offers 'non-invasive' treatment for prostate cancer. |
|
|
Jul 2, 2009 |
307 |
| Men with locally advanced prostate cancer are more likely to die if their doctors shorten the time they are treated with hormone-suppressing drugs, researchers reported. |
|
Brief article |
Jun 15, 2009 |
215 |
| Drug shows promise in treating drug-resistant prostate cancer. |
|
|
Jun 1, 2009 |
188 |
| Bristol-Myers Squibb Co (New York) said that interim results from two mid-stage studies of its leukemia drug Sprycel show that it could have potential as a treatment for a certain type of advanced prostate cancer. |
|
Brief article |
May 18, 2009 |
124 |
| GlaxoSmithKline Plc's drug Avodart reduces the risk of prostate cancer, results of a large clinical study showed. |
|
Brief article |
May 4, 2009 |
165 |
| A prostate cancer drug that takes a new approach to blocking tumor growth helped more than 40% of men with advanced prostate cancer, researchers reported. |
|
Brief article |
Apr 13, 2009 |
229 |
| Novel drug shows promise in treating drug-resistant prostate cancer. |
|
|
Apr 11, 2009 |
247 |
| Novel drug shows promise in treating drug-resistant prostate cancer. |
|
|
Apr 9, 2009 |
247 |
| Novel drug shows promise in treating drug-resistant prostate cancer. |
|
|
Apr 8, 2009 |
247 |
| New drug approved for advanced prostate cancer. |
Ninger, Laura J. |
Brief article |
Apr 1, 2009 |
262 |
| Increasing the sensitivity of advanced stage of prostate cancer to chemotherapeutic drugs-induced apoptosis by targeting miR-205 and miR-31. |
Bhatnagar, Namrata; Li, Xia; Guo, Bin |
Abstract |
Apr 1, 2009 |
290 |
| Prostate cancer evaluated with ferumoxtran-10-enhanced T2*-weighted MR imaging at 1.5 and 3.0 T: early experience. |
|
Brief article |
Mar 1, 2009 |
283 |
| Cancer drug breakthrough; In association with the NHS. |
|
|
Jan 26, 2009 |
239 |
| Measles virus may offer prostate cancer treatment. |
|
|
Jan 22, 2009 |
210 |
| Hormonal drug degarelix approved for treating advanced prostate cancer. |
Bates, Betsy |
|
Jan 15, 2009 |
534 |
| Hormonal drug approved for prostate cancer. |
Bates, Betsy |
|
Jan 15, 2009 |
538 |
| FDA approves drug for patients with advanced prostate cancer. |
|
|
Jan 1, 2009 |
196 |
| Prostate cancer news. |
|
Brief article |
Jan 1, 2009 |
183 |
